Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
IMNM
MLYS
Add up to 3 more stocks
IMNM
Immunome, Inc.
-6.02%
$19.89-1.28Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$1.90B
52W Range
$13.41 - $30.06
MLYS
Mineralys Therapeutics, Inc.
-4.89%
$22.16-1.14Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$1.95B
52W Range
$22.30 - $47.65
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.62 | 3.55 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 57.4% | 0.0% |
| Operating Margin | -3084.8% | 0.0% |
| Net Margin | -3060.0% | 0.0% |
| ROE | -48.4% | -63.5% |
| ROA | -45.0% | -52.3% |
| ROIC | -51.1% | -57.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 15.08 | 34.46 |
| Quick Ratio | 15.08 | 34.46 |
| Debt/Equity | 0.01 | 0.18 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.